As evidenced by the current Covid-19 pandemic, the human population remains highly susceptible to zoonotic viral threats. Novel respiratory-borne, viral pathogens are of particular concern, given their pathogenic potential, ease of transmission, and lack of effective “off-the-shelf” pharmaceutical interventions.
Read more